The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies

Interest in the role of coagulation and fibrinolysis in the nervous system was active in several laboratories dating back before cloning of the functional thrombin receptor in 1991. As one of those, our attention was initially on thrombin and plasminogen activators in synapse formation and eliminati...

Full description

Bibliographic Details
Main Authors: Barry W. Festoff, Chris Dockendorff
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/11/1558
_version_ 1797511062494380032
author Barry W. Festoff
Chris Dockendorff
author_facet Barry W. Festoff
Chris Dockendorff
author_sort Barry W. Festoff
collection DOAJ
description Interest in the role of coagulation and fibrinolysis in the nervous system was active in several laboratories dating back before cloning of the functional thrombin receptor in 1991. As one of those, our attention was initially on thrombin and plasminogen activators in synapse formation and elimination in the neuromuscular system, with orientation towards diseases such as amyotrophic lateral sclerosis (ALS) and how clotting and fibrinolytic pathways fit into its pathogenesis. This perspective is on neuro-thromboinflammation, emphasizing this emerging concept from studies and reports over more than three decades. It underscores how it may lead to novel therapeutic approaches to treat the ravages of neurotrauma and neurodegenerative diseases, with a focus on PAR1, ALS, and parmodulins.
first_indexed 2024-03-10T05:41:01Z
format Article
id doaj.art-36f1bcfe095544b190983c03e84c4a0e
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T05:41:01Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-36f1bcfe095544b190983c03e84c4a0e2023-11-22T22:32:56ZengMDPI AGBiomolecules2218-273X2021-10-011111155810.3390/biom11111558The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting TherapiesBarry W. Festoff0Chris Dockendorff1PHLOGISTIX LLC, Department of Neurology, University of Kansas Medical School, Kansas City, MO 64108, USAFunction Therapeutics LLC, Milwaukee, WI 53202, USAInterest in the role of coagulation and fibrinolysis in the nervous system was active in several laboratories dating back before cloning of the functional thrombin receptor in 1991. As one of those, our attention was initially on thrombin and plasminogen activators in synapse formation and elimination in the neuromuscular system, with orientation towards diseases such as amyotrophic lateral sclerosis (ALS) and how clotting and fibrinolytic pathways fit into its pathogenesis. This perspective is on neuro-thromboinflammation, emphasizing this emerging concept from studies and reports over more than three decades. It underscores how it may lead to novel therapeutic approaches to treat the ravages of neurotrauma and neurodegenerative diseases, with a focus on PAR1, ALS, and parmodulins.https://www.mdpi.com/2218-273X/11/11/1558neurodegenerationneurotraumaALSinflammationthromboinflammationneuro-thromboinflammation
spellingShingle Barry W. Festoff
Chris Dockendorff
The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
Biomolecules
neurodegeneration
neurotrauma
ALS
inflammation
thromboinflammation
neuro-thromboinflammation
title The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
title_full The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
title_fullStr The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
title_full_unstemmed The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
title_short The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
title_sort evolving concept of neuro thromboinflammation for neurodegenerative disorders and neurotrauma a rationale for par1 targeting therapies
topic neurodegeneration
neurotrauma
ALS
inflammation
thromboinflammation
neuro-thromboinflammation
url https://www.mdpi.com/2218-273X/11/11/1558
work_keys_str_mv AT barrywfestoff theevolvingconceptofneurothromboinflammationforneurodegenerativedisordersandneurotraumaarationaleforpar1targetingtherapies
AT chrisdockendorff theevolvingconceptofneurothromboinflammationforneurodegenerativedisordersandneurotraumaarationaleforpar1targetingtherapies
AT barrywfestoff evolvingconceptofneurothromboinflammationforneurodegenerativedisordersandneurotraumaarationaleforpar1targetingtherapies
AT chrisdockendorff evolvingconceptofneurothromboinflammationforneurodegenerativedisordersandneurotraumaarationaleforpar1targetingtherapies